Vaccine or not vaccine: that’s the question.
DOI:
https://doi.org/10.13129/1828-6550/APMB.110.2.2022.SD3Parole chiave:
children, COVID-19, efficacy, safety, vaccinationAbstract
In light of the most significant burden of COVID-19 in terms of severe disease and deaths, great progress have been made on the vaccination front with a significant reduction in the severe disease course, rate of hospitalization and deaths, especially in the older population, and also suffering from chronic diseases. Looking at the paediatric population, World Health Organization (WHO) and Food Drug Administration (FDA) are currently reviewing the scientific evidence on the need and timing of vaccinating the paediatric population with the currently available COVID-19 vaccines. Herein, we briefly summarized the impact of COVID-19 on the pediatric population and reported the most recent evidence on the efficacy and safety of COVID-19 vaccination in childrenRiferimenti bibliografici
1. Ministero della Salute. https://www.governo.it/it/cscovid19/report-vaccini/. Last Access 12 November 2022
2. Shati, A. A., Al-Qahtani, S. M., Alsabaani, A. A., Mahmood, S. E., Alqahtani, Y. A., AlQahtani, K. M., Aldarami, M. S., AlAmri, F. D., Alqahtani, A. S., AlHadi, A. M., Ahmad, A., &Riaz, F. A. (2022). Perceptions of Parents towards COVID-19 Vaccination in Children, Aseer Region, Southwestern Saudi Arabia. Vaccines, 10(8), 1222. https://doi.org/10.3390/vaccines10081222
3. Marziali, E., Lontano, A., Regazzi, L., Paladini, A., Villani, L., Calabrò, G. E., Damiani, G., Laurenti, P., Ricciardi, W., &Cadeddu, C. (2022). Factors Influencing the Choice to Advise for or against COVID-19 Vaccination in the Physicians and Dentists of an Italian Region. Vaccines, 10(11), 1793. https://doi.org/10.3390/vaccines10111793
4. World Health Organization. https://www.who.int/emergencies/diseases/novel-coronavirus-2019?adgroupsurvey={adgroupsurvey}&gclid=EAIaIQobChMIlIy34sC6-wIVxQOLCh2UIg8xEAAYASAAEgL30_D_BwE. Last Access: September 28, 2021
5. Perrone, S., Cannavò, L., Manti, S., Rullo, I., Buonocore, G., Esposito, S. M. R., &Gitto, E. (2022). Pediatric Multisystem Syndrome Associated with SARS-CoV-2 (MIS-C): The Interplay of Oxidative Stress and Inflammation. International journal of molecular sciences, 23(21), 12836
https://doi.org/10.3390/ijms232112836
6. Holm, M., Espenhain, L., Glenthøj, J., Schmidt, L. S., Nordly, S. B., Hartling, U. B., &Nygaard, U. (2022). Risk and Phenotype of Multisystem Inflammatory Syndrome in Vaccinated and Unvaccinated Danish Children Before and During the Omicron Wave. JAMA pediatrics, 176(8), 821–823. https://doi.org/10.1001/jamapediatrics.2022.2206
7. Lopez-Leon, S., Wegman-Ostrosky, T., Ayuzo Del Valle, N. C., Perelman, C., Sepulveda, R., Rebolledo, P. A., Cuapio, A., &Villapol, S. (2022). Long-COVID in children and adolescents: a systematic review and meta-analyses. Scientific reports, 12(1), 9950. https://doi.org/10.1038/s41598-022-13495-5
8. Tan, S. H. X., Cook, A. R., Heng, D., Ong, B., Lye, D. C., & Tan, K. B. (2022). Effectiveness of BNT162b2 Vaccine against Omicron in Children 5 to 11 Years of Age. The New England journal of medicine, 387(6), 525–532. https://doi.org/10.1056/NEJMoa2203209
9. Sacco, C., Del Manso, M., Mateo-Urdiales, A., Rota, M. C., Petrone, D., Riccardo, F., Bella, A., Siddu, A., Battilomo, S., Proietti, V., Popoli, P., Menniti Ippolito, F., Palamara, A. T., Brusaferro, S., Rezza, G., Pezzotti, P., Fabiani, M., &Italian National COVID-19 IntegratedSurveillance System and the Italian COVID-19 vaccinesregistry (2022). Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022. Lancet (London, England), 400(10346), 97–103. https://doi.org/10.1016/S0140-6736(22)01185-0
10. Hause, A. M., Shay, D. K., Klein, N. P., Abara, W. E., Baggs, J., Cortese, M. M., Fireman, B., Gee, J., Glanz, J. M., Goddard, K., Hanson, K. E., Hugueley, B., Kenigsberg, T., Kharbanda, E. O., Lewin, B., Lewis, N., Marquez, P., Myers, T., Naleway, A., Nelson, J. C., Shimabukuro, T. T. (2022). Safety of COVID-19 Vaccination in United States Children Ages 5 to 11 Years. Pediatrics, 150(2), e2022057313.https://doi.org/10.1542/peds.2022-057313
11. World Health Organization https://www.who.int/emergencies/diseases/novel-coronavirus-2019?adgroupsurvey={adgroupsurvey}&gclid=EAIaIQobChMIlIy34sC6-wIVxQOLCh2UIg8xEAAYASAAEgL30_D_BwE. Last Access: 11 August 2022 Statement
FDA. https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-moderna-and-pfizer-biontech-bivalent-covid-19-vaccines. Last Access: 19 November, 2022
Dowloads
Pubblicato
Fascicolo
Sezione
Licenza
This work is licensed under a Creative Commons Attribution 4.0 International License.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
